← Open Payments lookup

AUDREY SCHILLING: Open Payments

NPI 1225405590 · STARKVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,528 in 80 payments from 20 companies in 2025. Trend: 2023 $1,356 · 2024 $1,998 · 2025 $1,528

Food & beverage: $1,528
CompanyPaymentsAmount
ABBVIE INC.17$231
Novo Nordisk Inc13$220
AstraZeneca Pharmaceuticals LP10$213
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$211
Lilly USA, LLC10$173
Bayer Healthcare Pharmaceuticals Inc.4$81
Astellas Pharma US Inc3$64
Averitas Pharma Inc.2$52
Abbott Laboratories2$47
Boehringer Ingelheim Pharmaceuticals, Inc.2$37

Products named: CAPLYTA, MOUNJARO, AIRSUPRA, Wegovy, UBRELVY, Kerendia, FARXIGA, Ozempic.

Industry payments across MS — which companies pay providers there.